The Vall d'Hebron University Hospital is a public and university affiliated hospital founded in 1955. It belongs to the Catalan Health Institute and is the hospital complex with the highest volume of interventions in Catalonia, Spain.

There are 1,146 beds in Hospital Universitario Hebron, gynecology department.

During the past decade, Hospital Universitario Hebron, gynecology department conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Hebron, gynecology department" are "Uterine Fibroids" (2 trials). Many other conditions were trialed in "Hospital Universitario Hebron, gynecology department" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Hebron, gynecology department" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "PGL4001, placebo" (1 trials), "PGL4001, placebo, drug free period" (1 trials), "PGL4001, progestin" (1 trials) and "PGL4001, progestin, drug free period" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Hebron, gynecology department" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Universitario Hebron, gynecology department". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital Universitario Hebron, gynecology department, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Hebron, gynecology department, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".